Format

Send to

Choose Destination
See comment in PubMed Commons below
J Am Pharm Assoc (Wash). 2002 Sep-Oct;42(5 Suppl 1):S36-7.

Managing dyslipidemias: update on guidelines and pharmacotherapy.

Author information

1
Massachusetts College of Pharmacy and Health Sciences, Boston, USA.

Abstract

New guidelines, the Adult Treatment Panel III (ATP III), for diagnosis and treatment of dyslipidemias are more stringent than older ones. Based on ATP III, 65 million Americans need therapeutic lifestyle changes, 36.5 million of whom require drug therapy. Guidelines do not work unless implemented--and therein lies an important role for pharmacists. Pharmacists in many different practice settings can screen patients for lipid disorders, assist in implementing treatment of high cholesterol levels, and maintain contact with patients with these chronic, common conditions.

PMID:
12296547
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Loading ...
    Support Center